$0.72
2.38% today
Nasdaq, May 13, 09:19 pm CET
ISIN
US50107A1043
Symbol
KRON
Sector
Industry

Kronos Bio Inc Stock price

$0.74
-0.12 13.70% 1M
-0.18 19.55% 6M
-0.21 22.09% YTD
-0.28 27.44% 1Y
-3.26 81.50% 3Y
-18.26 96.10% 5Y
-18.26 96.10% 10Y
Nasdaq, Closing price Mon, May 12 2025
+0.02 2.56%
ISIN
US50107A1043
Symbol
KRON
Sector
Industry

Key metrics

Market capitalization $45.12m
Enterprise Value $-30.52m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.56
EV/Sales (TTM) EV/Sales -3.32
P/S ratio (TTM) P/S ratio 4.91
P/B ratio (TTM) P/B ratio 0.57
Revenue growth (TTM) Revenue growth 21.15%
Revenue (TTM) Revenue $9.19m
EBIT (operating result TTM) EBIT $-50.60m
Free Cash Flow (TTM) Free Cash Flow $-54.38m
Cash position $99.73m
EPS (TTM) EPS $-1.07
P/E forward negative
Short interest 1.44%
Show more

Is Kronos Bio Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,793 stocks worldwide.

Kronos Bio Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Kronos Bio Inc forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a Kronos Bio Inc forecast:

Hold
100%

Financial data from Kronos Bio Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
9.19 9.19
21% 21%
100%
- Direct Costs 1.59 1.59
40% 40%
17%
7.60 7.60
54% 54%
83%
- Selling and Administrative Expenses 21 21
40% 40%
227%
- Research and Development Expense 36 36
54% 54%
389%
-49 -49
54% 54%
-533%
- Depreciation and Amortization 1.59 1.59
40% 40%
17%
EBIT (Operating Income) EBIT -51 -51
54% 54%
-551%
Net Profit -64 -64
45% 45%
-702%

In millions USD.

Don't miss a Thing! We will send you all news about Kronos Bio Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kronos Bio Inc Stock News

Neutral
Business Wire
9 days ago
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Kronos Bio, Inc. (NasdaqGS: KRON) to Concentra Biosciences, LLC. Under the terms of the proposed transaction, shareholders of Kronos will receive $0.57 in cash per share plus one non-tradeable cont...
Neutral
Business Wire
12 days ago
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Kronos (Nasdaq: KRON) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shar...
Neutral
Business Wire
12 days ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Kronos Bio, Inc. (NASDAQ: KRON) to Concentra Biosciences, LLC for $0.57 in cash per share plus one non-tradeable contingent value right is fair to Kronos shareholders. Halper Sadeh encourages Kronos shareholders to click here to learn more about their legal rights and options or contac...
More Kronos Bio Inc News

Company Profile

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic transcription factors, small cell, prostate cancer, and MYC-driven cancers. The company was founded by Angela Koehler and Joshua Kazam in 2017 and is headquartered in Cambridge, MA.

Head office United States
CEO Deborah Knobelman
Employees 10
Founded 2017
Website www.kronosbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today